"For example, GLP-1s are used for the treatment of type 2 diabetes or weight loss
Goldwirt, L., Beccaria, K., Ple, A., Sauvageon, H
Human clinical evidence is still limited, so this page is published by The Peptide Guide for informational, educational, and research reference purposes onlynot as medical advice or a treatment protocol
The best available evidence suggests retatrutide can produce major fat-mass reduction and that lean-mass loss, relative to total weight loss, appears similar to other obesity therapies rather than disproportionately worse
Orforglipron belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists
R., Janus, C., Stallknecht, B